Resources

PIR International recently partnered with Closed Loop Medicine in appointing Luba Greenwood as Non-Executive Chair

Cushman & Wakefield's Locating Science life sciences report wins top award from the Society of Property Researchers

Pension reform unlocks cash for UK life sciences, London Life Sciences Week and #bioProcessUK are here.

OMass Therapeutics, a biotechnology company identifying medicines against highly validated target ecosystems such as membrane proteins or intracellular complexes, today announces the appointment of Professor Steven Charlton as Chief Scientific Officer (CSO).

Greywolf Therapeutics, a clinical-stage biotech company advancing novel antigen modulation technology that controls T cells to guide the immune system, has appointed Darlene Deptula-Hicks as Chief Financial Officer.

The Rosalind Franklin Institute has appointed four new trustees: Malcolm Skingle, Hilary Newiss, Bruce Pritchard and Caroline Carter.

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, recently partnered with IMU Biosciences and is pleased to announce the placements of Dr John Baker as Chief Executive Officer and Dr Jason Brown as Chief Business Officer.

Babraham Research Campus Ltd, which is responsible for the development and management of Babraham Research Campus is delighted to announce the appointment of Dr Louise Jopling to the newly created role of Chief Scientific & Innovation Officer.

PIR International recently partnered with SynaptixBio and is pleased to announce the appointment of Uwe Meya as Chief Medical Officer.

Tessellate BIO today announces the appointment of Dr. Lara Boyd as Chief Business Officer.

RoslinCT announces the appointment of Jessica Carmen, Ph.D., to its global leadership team as Chief Commercial Officer.

Luba Greenwood is a distinguished executive, investor, and company builder with over 20 years of experience in the healthcare and tech sectors.

Ingenza welcomes Lisa Fraser as she takes on the role of Senior Project Manager, effective immediately.

Mayer Schreiber, CEO of Discovery Park, comments after the historic budget.

GitLife Biotech Ltd. has appointed Beatrix Ellis as its new CEO. With extensive experience in commercial strategy and business development, this appointment marks a pivotal moment for GitLife.

We are excited to welcome the newly elected members of the BIA Board of Directors, who will bring fresh insights and expertise to help drive our mission forward. Nick Gardiner shares his perspective on the importance of these appointments and the unique value each new Director brings to the BIA.

Coulter Partners successfully completed a search assignment for ArcticZymes Technologies ASA (OSE: AZT) and is pleased to announce the placement of Dr. Frank Mathias as Chair of the Board.

BioPartner UK announces the appointment of Mike Fisher, PhD, VP and Head of Business Development at Oncimmune, to its Advisory Board.